Similarly, in breast carcinoma cell lines, HER2 overexpression increases the ALDH-expressing BCIC population, which displays enhanced expression of stem cell regulatory genes and exhibits increased invasion in vitro and increased tumorigenicity in the humanized mammary fat pad of NOD/SCID mice [48]. Here, ERBB2 is linked to breast carcinoma.